Farnier M - Search Results

1

Efficacy and safety of the coadministration of ezetimibe/simvastatin with fenofibrate in patients with mixed hyperlipidemia.

Farnier M, Roth E, Gil-Extremera B, Mendez GF, Macdonell G, Hamlin C, Perevozskaya I, Davies MJ, Kush D, Mitchel YB; Ezetimibe/Simvastatin + Fenofibrate Study Group. Farnier M, et al. Am Heart J. 2007 Feb;153(2):335.e1-8. doi: 10.1016/j.ahj.2006.10.031. Am Heart J. 2007. PMID: 17239698 Clinical Trial.

2

Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia.

Farnier M, Bonnefous F, Debbas N, Irvine A. Farnier M, et al. Arch Intern Med. 1994 Feb 28;154(4):441-9. Arch Intern Med. 1994. PMID: 8117177 Clinical Trial.

3

Current and future treatment of hyperlipidemia: the role of statins.

Farnier M, Davignon J. Farnier M, et al. Am J Cardiol. 1998 Aug 27;82(4B):3J-10J. doi: 10.1016/s0002-9149(98)00423-8. Am J Cardiol. 1998. PMID: 9737640 Review.

4

Plasma lipoprotein distribution and lipid transfer activities in patients with type IIb hyperlipidemia treated with simvastatin.

Lagrost L, Athias A, Lemort N, Richard JL, Desrumaux C, Châtenet-Duchêne L, Courtois M, Farnier M, Jacotot B, Braschi S, Gambert P. Lagrost L, et al. Among authors: farnier m. Atherosclerosis. 1999 Apr;143(2):415-25. doi: 10.1016/s0021-9150(98)00299-8. Atherosclerosis. 1999. PMID: 10217372 Clinical Trial.

5

Efficacy of atorvastatin compared with simvastatin in patients with hypercholesterolemia.

Farnier M, Portal JJ, Maigret P. Farnier M, et al. J Cardiovasc Pharmacol Ther. 2000 Jan;5(1):27-32. doi: 10.1177/107424840000500104. J Cardiovasc Pharmacol Ther. 2000. PMID: 10687671 Clinical Trial.

6

Effect of combined fluvastatin-fenofibrate therapy compared with fenofibrate monotherapy in severe primary hypercholesterolemia. French Fluvastatin Study Group.

Farnier M, Dejager S. Farnier M, et al. Am J Cardiol. 2000 Jan 1;85(1):53-7. doi: 10.1016/s0002-9149(99)00606-2. Am J Cardiol. 2000. PMID: 11078237 Clinical Trial.

7

Ezetimibe in hypercholesterolaemia.

Farnier M. Farnier M. Int J Clin Pract. 2002 Oct;56(8):611-4. Int J Clin Pract. 2002. PMID: 12425372

8

Frequency of creatine kinase elevation during treatment with fluvastatin in combination with fibrates (bezafibrate, fenofibrate, or gemfibrozil).

Farnier M, Bortolini M, Salko T, Freudenreich MO, Isaacsohn JL, Troendle AJ, Gonasun L. Farnier M, et al. Am J Cardiol. 2003 Jan 15;91(2):238-40. doi: 10.1016/s0002-9149(02)03116-8. Am J Cardiol. 2003. PMID: 12521642 No abstract available.

9

Effects of baseline level of triglycerides on changes in lipid levels from combined fluvastatin + fibrate (bezafibrate, fenofibrate, or gemfibrozil).

Farnier M, Salko T, Isaacsohn JL, Troendle AJ, Dejager S, Gonasun L. Farnier M, et al. Am J Cardiol. 2003 Oct 1;92(7):794-7. doi: 10.1016/s0002-9149(03)00885-3. Am J Cardiol. 2003. PMID: 14516878

10

Combination therapy with an HMG-CoA reductase inhibitor and a fibric acid derivative: a critical review of potential benefits and drawbacks.

Farnier M. Farnier M. Am J Cardiovasc Drugs. 2003;3(3):169-78. doi: 10.2165/00129784-200303030-00003. Am J Cardiovasc Drugs. 2003. PMID: 14727929 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters